For more than 40 years, we’ve developed software for scientists by scientists — a hallmark, unrivaled in our industry. For that reason, eight of the w...
Switzerland
News
Categories
Ascentos 2.0
Ascentos 2.0 coming November 29, 2019
With significant performance improvements and innovative new features, ASCENTOS 2.0 will be the new benchmark in the non-clinical space
Accelerating Time to Market – Regulatory Submission Reporting
A few of the advanced features are
Integrated pharmacy and formulation
New post-dosing clinical observation scheduling
Integrated histology workflow engine
Multi strain per study
New licensing options for maximum scalability
It is our most comprehensive release in PDS’ history with an extra focus on quality…
Performed a comprehensive script review with extra QA oversight
Included multiple phases of beta and release testing for stability and compatibility with previous functionality
Our current Ascentos customers can arrange a walk-through session to preview the enhancements. If you are new to Ascentos please click here to learn more about your options.
For more than 39 years, we’ve developed software for scientists by scientists — a hallmark, unrivaled in our industry. For that reason, eight of the world’s top 10 pharma companies have relied on PDS, as do leading CROs, chemical companies, universities, and regulatory agencies.
Innovation, GLP Compliance, and intuitive SaaS solutions our the cornerstones of our success. Our SaaS platforms for SEND and LIMS are designed from the ground up to meet CDISC, ISO, and GLP standards.
For more than 40 years, we’ve developed software for scientists by scientists — a hallmark, unrivaled in our industry. For that reason, eight of the world’s top 10 pharma companies have relied on PDS, as do leading CROs, chemical companies, universit...
